e-Therapeutics Plc
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 2003-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours
- Conditions
- Hepatocellular CarcinomaPancreatic Cancer
- Interventions
- First Posted Date
- 2015-04-22
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- e-Therapeutics PLC
- Target Recruit Count
- 112
- Registration Number
- NCT02423239
- Locations
- 🇩🇪
University Hospital Bonn, Study Center Bonn (SZB) Clinical Study Core Unit Institute of Clinical Chemistry and Clinical Pharmacology University Hospital Bonn, Sigmund-Freud-Str. 25, Bonn, Germany
🇩🇪Universitätsklinikum Hamburg-Eppendorf II. Medizinischen Klinik Martinistr. 52, Hamburg, Germany
🇩🇪Klinikum der Ruhr-Universitaet Bochum, Medizinische Klinik III - Hämatologie/Onkologie Marien Hospital Herne Universitätsklinikum der Ruhr-Universität Bochum Hölkeskampring 40, Herne, Germany
Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects
- Conditions
- TolerabilitySafetyCancerPharmacokinetics
- Interventions
- First Posted Date
- 2014-02-04
- Last Posted Date
- 2016-05-23
- Lead Sponsor
- e-Therapeutics PLC
- Target Recruit Count
- 40
- Registration Number
- NCT02054754
- Locations
- 🇬🇧
Quotient Clinical, Nottingham, Nottinghamshire, United Kingdom
Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2013-12-18
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- e-Therapeutics PLC
- Target Recruit Count
- 164
- Registration Number
- NCT02014363
- Locations
- 🇬🇧
CPS Research, Glasgow, Scotland, United Kingdom
A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours
- First Posted Date
- 2011-12-12
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- e-Therapeutics PLC
- Target Recruit Count
- 40
- Registration Number
- NCT01489826
- Locations
- 🇬🇧
Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
🇬🇧Northern Centre for Cancer Care, Freeman Hospital, Newcastle-upon-Tyne, UK, Newcastle-upon-Tyne, Tyne and Wear, United Kingdom
🇬🇧The Beatson West of Scotland Cancer Centre,, Glasgow, United Kingdom